The investigative findings of patients considered to have possible hypertrophic cardiomyopathy were examined, and 31 of these fulfilling defined criteria for the disease were reviewed in detail, with emphasis on thyroid abnormalities. Four patients had a history of thyroid disease (13%). Explanations considered for the apparent association were the effects of hyperthyroidism on normal, or more probably, incipiently abnormal myocardium.
That hyperthyroidism may produce or precipitate hypertrophic cardiomyopathy (HOCM) has been suggested by Symons et al. (1974) , who cited supporting clinical and necropsy evidence. A patient with both conditions excited our interest in 1971, since when thyroid function tests have been performed on patients with suspected or proven HOCM. We present here the findings in a series of 31 cases where the diagnosis was validated, with details of thyroid function tests, and the incidence of clinical thyroid disease.
Patients and methods
Angiocardiograms, echocardiograms, and haemodynamic data were initially examined, and patients with positive features were called for outpatient review between November 1976 and May 1977. A symptomatic history was taken, concentrating on symptoms suggesting past hyperthyroidism, and a family history, including thyroid and autoimmune disorders. Clinical examination, chest x-ray film, electrocardiogram, and echocardiogram were repeated, and blood taken for thyroxine (T3 and T4), TSH, T3 resin uptake, and thyroid antibody screening.
Because most patients, when examined, were taking beta-adrenergic blocking drugs, clinical signs were rejected as criteria for inclusion in the study. An adequate, diagnostic, left ventricular angiogram was accepted, where available, but other previously described features presented difficulty.
Braunwald and Aygen (1963) were frequently non-diagnostic, though 21 patients showed a mid to late systolic murmur. Radiologically, 15 cases showed pulmonary venous congestion, but aortic dilatation was seen in one case only. Electrocardiograms showed 'anterior infarction' patterns in 7 cases, and 'inferior infarction' in 2. LV hypertrophy changes are related to LV outflow gradients in the Figure, and, as found by Walston et al. (1971) , all cases but one with resting gradients showed some evidence of left ventricular hypertrophy. The Table shows 150) . Thyrotoxic symptoms recurred after 9 months carbimazole, and radioiodine uptake at 2 hours was increased at 48 per cent. Radioiodine therapy is now being considered.
Among patients excluded from the series because diagnostic criteria for HOCM were not entirely fulfilled, was one woman with a history of thyroid disease, though records of radioiodine therapy in 1961 were untraceable. She showed an increased ejection fraction on RAO angiogram, a variable LV outflow gradient reaching 120 mmHg with isoprenaline, and probable septal hypertrophy on poorly defined echocardiograms. TSH was increased at review, at 11 0 mU/l (less than 6 0).
Discussion
The difficulties of diagnosing clinically hyperthyroidism with HOCM have been outlined by Symons et al. (1974) . Cardiac catheterisation findings in our cases were unremarkable, except that 2 of the patients with thyroid disease (cases 1 and 2) showed right ventricular, infundibular gradients in the absence of any left-sided gradient, a feature of only 2 other cases in the series.
It is difficult to validate clinical associations by comparison with controls in a series of this size, and we did not attempt this. Nevertheless, an incidence of 13 per cent of cases having thyroid disease appears largely to be a chance finding. If genuine, the connection has a number of possible explanations. One is that increased circulating thyroid hormones may produce HOCM in a previously normal heart. It has recently been shown, by Olsen et al. (1977) , working with pregnant rats, that thyroxine analogues can produce, in the offspring, ultrastructural changes in the myocardium similar to those of HOCM. This was more pronounced with larger doses, and no such changes occurred in adult rats, even on high dose regimens. The connection with human disease is not clear, and a history of maternal thyroid disease was not noted in any of our patients. Electrocardiographic evidence of severe LV hypertrophy appears uncommon in thyrotoxic heart disease, though some myocardial hypertrophy (occasionally severe) is well recognised at necropsy. These observations accord with the cardiac effects of hyperthyroidism, probably arising from thyroid hormone activity, rather than induced catecholamine hypersensitivity (Aoki et al., 1972) .
Another possibility is that hyperthyroidism exacerbates or precipitates HOCM where there is an incipient myocardial abnormality. Symons et al. (1974) described 3 cases with both conditions, and in 2 of them myocardial histology indicated HOCM in 1, but was non-specific in the other.
Since even severe hyperthyroidism does not consistently result in HOCM, the second explanation appears the more probable, and the high incidence of echocardiographic abnormalities found by Henry et al. (1973b) in first degree relatives of HOCM patients suggests, firstly, that most, possibly all, cases have a hereditary basis, and, secondly, that some additional factor may be needed to produce clinical disease. Further information may accrue from echocardiographic screening of a thyrotoxic population. 
